Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder
Clinical trial NCT05626959 · UNKNOWN
Trial details
- NCT number
- NCT05626959
- Sponsor
- Fenix Innovation Group
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2023-03-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.